Barclays
MANE icon

Barclays’s Veradermics Inc MANE Stock Holding History

Barclays’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.16M Buy
50,829
+36,123
+246% +$3.95M ﹤0.01% 1921
2026
Q2 		$1.81M Sell
14,706
-22,205
-60% -$2.08M ﹤0.01% 2403
2026
Q1 		$2.33M Buy
+36,911
New +$1.86M ﹤0.01% 2254

Other funds holding MANE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Barclays's MANE Position: Q3 2026 in Review

Barclays increased its Veradermics Inc (MANE) stake by 246% in Q3 2026, buying an estimated $3.95M and bringing the position to 50,829 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Barclays first reported a position in MANE in Q1 2026 and has held it in 3 quarters since. 82 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Barclays held 50,829 shares of Veradermics Inc worth $6.16M as of Q3 2026.
  • Barclays bought 36,123 Veradermics Inc shares in Q3 2026, an estimated $3.95M.
  • Veradermics Inc made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1921 holding.
  • Barclays first reported a position in Veradermics Inc in Q1 2026 and has held it in 3 quarters since.
  • 82 funds tracked by Wall St. Rank held Veradermics Inc as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.